El Bassam Souad, Pinsonneault Stéphane, Kornfeld Hardy, Ren Fucheng, Menezes José, Laberge Sophie
Laboratory of Immunology, Research Center, Ste-Justine Hospital, University of Montreal, Canada.
Immunology. 2006 Jan;117(1):89-96. doi: 10.1111/j.1365-2567.2005.02269.x.
Expression of interleukin (IL)-16 is increased in bronchial mucosal biopsies of atopic asthmatics compared to normal controls. The functional significance of increased expression of IL-16 at sites of allergic inflammation is not yet clear. We have previously shown that IL-16 inhibits IL-5 secretion by allergen-stimulated peripheral blood mononuclear cells (PBMC). We investigated whether IL-16 inhibits the production of other T helper 2 cytokines, namely IL-13 and IL-4, by allergen-specific T cells. PBMC from ragweed-sensitive atopic subjects were stimulated with allergen extract for cytokine production in the presence or absence of rhIL-16. Production of cytokines was assessed by enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction. To evaluate whether the modulatory effect of IL-16 on cytokine synthesis was mediated by interferon-gamma (IFN-gamma), IL-10, IL-12 or IL-18, allergen-stimulated PBMC were cultured in presence of IL-16 and neutralizing concentrations of relevant antibodies. Allergen-stimulated PBMC produced significantly elevated levels of IL-13 (90-740 pg/ml) as compared to unstimulated PBMC (0-375 pg/ml, P < 0.01). Addition of rhIL-16 resulted in down-regulation of IL-13 mRNA expression as well as significantly reduced amounts of IL-13 released by allergen-stimulated PBMC (0-457 pg/ml, P < 0.001), as observed for IL-5. No effect of IL-16 was observed on IL-4 mRNA expression. Treatment with IL-16 resulted in increased levels of IL-10 and IL-18 in allergen-stimulated cell culture. Neutralization of IFN-gamma, IL-12, IL-10 or IL-18 did not alter the inhibitory effects of IL-16 on IL-13 and IL-5 secretion by allergen-stimulated PBMC. IL-16 did not modify IL-13 synthesis by anti-CD3-stimulated CD4(+) T cells, but it significantly reduced the production of IL-5. These data suggest that IL-16 may play an important immunoregulatory role in allergic states in response to allergen.
与正常对照组相比,特应性哮喘患者支气管黏膜活检中白细胞介素(IL)-16的表达增加。IL-16在变应性炎症部位表达增加的功能意义尚不清楚。我们之前已经表明,IL-16可抑制变应原刺激的外周血单核细胞(PBMC)分泌IL-5。我们研究了IL-16是否抑制变应原特异性T细胞产生其他辅助性T细胞2细胞因子,即IL-13和IL-4。在有或无重组人IL-16(rhIL-16)存在的情况下,用变应原提取物刺激豚草敏感的特应性受试者的PBMC以产生细胞因子。通过酶联免疫吸附测定和逆转录-聚合酶链反应评估细胞因子的产生。为了评估IL-16对细胞因子合成的调节作用是否由干扰素-γ(IFN-γ)、IL-10、IL-12或IL-18介导,在存在IL-16和中和浓度的相关抗体的情况下培养变应原刺激的PBMC。与未刺激的PBMC(0 - 375 pg/ml,P < 0.01)相比,变应原刺激的PBMC产生的IL-13水平显著升高(90 - 740 pg/ml)。添加rhIL-16导致IL-13 mRNA表达下调,以及变应原刺激的PBMC释放的IL-13量显著减少(0 - 457 pg/ml,P < 0.001),IL-5的情况也是如此。未观察到IL-16对IL-4 mRNA表达有影响。用IL-16处理导致变应原刺激的细胞培养物中IL-10和IL-18水平升高。中和IFN-γ、IL-12、IL-10或IL-18并没有改变IL-16对变应原刺激的PBMC分泌IL-13和IL-5的抑制作用。IL-16并没有改变抗CD3刺激的CD4(+) T细胞合成IL-13,但它显著降低了IL-5的产生。这些数据表明,IL-16可能在变应性状态下对变应原的反应中发挥重要的免疫调节作用。